Form 4: Benitec Biopharma Director J. Kevin Buchi Gifts Shares to Trust

Director J. Kevin Buchi reported gifting 103,626 shares of Benitec Biopharma Inc. common stock to a trust on March 12, 2025.

Summary

• On March 12, 2025, J. Kevin Buchi, a director of Benitec Biopharma Inc., gifted 103,626 shares of common stock to a trust.
• The reporting person is the trustee of the trust, and his son is the sole beneficiary.
• The transaction was reported on a Form 4 filing with the SEC on March 13, 2025.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing a transaction. It doesn't inherently convey positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction represents a transfer of shares from the director to a trust, which may have estate planning or tax implications for the individual.

Related Party Transactions

• The gift of shares to a trust where the reporting person is the trustee and his son is the beneficiary constitutes a related party transaction.

Stakeholder Impact

• The transaction has minimal direct impact on stakeholders, as it is a transfer of ownership within a family trust and does not affect the company's operations or financial position.

Key Dates